Tianyu Biotech announced that in August 2023, the company applied for arbitration on the grounds that Liu Bingsheng had not fulfilled his performance compensation obligation, and in June 2025, the Arbitration Commission ruled that Liu Bingsheng should pay 43.2953 million yuan in compensation and arbitration fees of 314,300 yuan. Due to Lau Ping-sang's failure to comply, the company applied for enforcement. Recently, the company received the court's “Enforcement Ruling” and terminated the execution procedure because no evidence of Lau Ping-sang's property could be executed was found. Subsequently, Liu Bingsheng was still obligated to pay. The company discovered that it had enforceable assets and could apply to resume execution. The impact of this arbitration on the company's profits is yet to be determined.

Tianyu Biotech announced that in August 2023, the company applied for arbitration on the grounds that Liu Bingsheng had not fulfilled his performance compensation obligation, and in June 2025, the Arbitration Commission ruled that Liu Bingsheng should pay 43.2953 million yuan in compensation and arbitration fees of 314,300 yuan. Due to Lau Ping-sang's failure to comply, the company applied for enforcement. Recently, the company received the court's “Enforcement Ruling” and terminated the execution procedure because no evidence of Lau Ping-sang's property could be executed was found. Subsequently, Liu Bingsheng was still obligated to pay. The company discovered that it had enforceable assets and could apply to resume execution. The impact of this arbitration on the company's profits is yet to be determined.